Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain.
Airam de Burgos-GonzalezConsuelo Huerta-ÁlvarezMaría José PeñalverLuis SordoJosé PulidoLucía Cea SorianoPublished in: Pharmacoepidemiology and drug safety (2022)
There was a trend towards and increased risk of excess bleeds when using concomitantly with dabigatran. The effect decreases with a narrower definition of current use.